1. Home
  2. HALO vs LUMN Comparison

HALO vs LUMN Comparison

Compare HALO & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • LUMN
  • Stock Information
  • Founded
  • HALO 1998
  • LUMN 1968
  • Country
  • HALO United States
  • LUMN United States
  • Employees
  • HALO N/A
  • LUMN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • LUMN Telecommunications Equipment
  • Sector
  • HALO Health Care
  • LUMN Telecommunications
  • Exchange
  • HALO Nasdaq
  • LUMN Nasdaq
  • Market Cap
  • HALO 6.4B
  • LUMN 6.6B
  • IPO Year
  • HALO N/A
  • LUMN 1972
  • Fundamental
  • Price
  • HALO $50.51
  • LUMN $5.82
  • Analyst Decision
  • HALO Buy
  • LUMN Hold
  • Analyst Count
  • HALO 9
  • LUMN 8
  • Target Price
  • HALO $61.11
  • LUMN $4.89
  • AVG Volume (30 Days)
  • HALO 1.3M
  • LUMN 12.0M
  • Earning Date
  • HALO 02-18-2025
  • LUMN 02-04-2025
  • Dividend Yield
  • HALO N/A
  • LUMN N/A
  • EPS Growth
  • HALO 61.71
  • LUMN N/A
  • EPS
  • HALO 3.02
  • LUMN N/A
  • Revenue
  • HALO $947,355,000.00
  • LUMN $13,296,000,000.00
  • Revenue This Year
  • HALO $23.36
  • LUMN N/A
  • Revenue Next Year
  • HALO $15.35
  • LUMN N/A
  • P/E Ratio
  • HALO $16.69
  • LUMN N/A
  • Revenue Growth
  • HALO 21.35
  • LUMN N/A
  • 52 Week Low
  • HALO $33.15
  • LUMN $0.97
  • 52 Week High
  • HALO $65.53
  • LUMN $10.33
  • Technical
  • Relative Strength Index (RSI)
  • HALO 59.63
  • LUMN 42.31
  • Support Level
  • HALO $47.52
  • LUMN $5.22
  • Resistance Level
  • HALO $49.00
  • LUMN $6.46
  • Average True Range (ATR)
  • HALO 1.39
  • LUMN 0.32
  • MACD
  • HALO 0.38
  • LUMN 0.02
  • Stochastic Oscillator
  • HALO 93.30
  • LUMN 44.85

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About LUMN Lumen Technologies Inc.

With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 has shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.

Share on Social Networks: